CHK
43
2
PHM
71
2
KMI
46
-2
INTC
36
-5
VRSN
48
-5
DGX
46
-2
BEN
52
10
VZ
30
3
HOG
33
6
ABT
50
3
ZBH
48
-2
COP
51
-2
MET
45
5
HST
49
-3
VRTX
58
-2
CCL
41
-3
EL
52
4
IR
83
3
MPC
52
10
VTR
78
2
CHK
43
2
PHM
71
2
KMI
46
-2
INTC
36
-5
VRSN
48
-5
DGX
46
-2
BEN
52
10
VZ
30
3
HOG
33
6
ABT
50
3
ZBH
48
-2
COP
51
-2
MET
45
5
HST
49
-3
VRTX
58
-2
CCL
41
-3
EL
52
4
IR
83
3
MPC
52
10
VTR
78
2
Financhill
Back

ProShares Ultra Nasdaq Biotechnology Stock Predictions

This trade could move overnight Thursday!

Access my free presentation on these overnight trades right here
Sell
38

BIB
ProShares Ultra Nasdaq Biotechnology

Last Price:
49.85
Seasonality Move:
11.63%

7 Day Trial

ALL ACCESS PASS

$ 7

BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty

Click here now to prepare yourself for what's around the corner

ProShares Ultra Nasdaq Biotechnology Stock Forecast

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 23.2% based on the past 14 years of stock performance.
  • ProShares Ultra Nasdaq Biotechnology has risen higher in 8 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
  • Is ProShares Ultra Nasdaq Biotechnology Stock Undervalued?
    The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $49.66. The Score for BIB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • BIB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will ProShares Ultra Nasdaq Biotechnology Stock Go Up Next Year?

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 23.2% based on the past 14 years of stock performance.

ProShares Ultra Nasdaq Biotechnology Stock Rating

Sell
38
ProShares Ultra Nasdaq Biotechnology (BIB) is a Sell

Is ProShares Ultra Nasdaq Biotechnology overpriced?

  • ProShares Ultra Nasdaq Biotechnology has risen higher in 8 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%

ProShares Ultra Nasdaq Biotechnology Stock Price History

Is BIB stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIB is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
62.45
52-Week Low:
40.10

Prediction Charts

Market Cap:
0
Price in USD:
49.66
Volume:
8.47K
Beta:
1.83

Technical Analysis

SMA50:
55.36
SMA100:
55.60
SMA200:
52.01
52-Wk Change:
-8.6%

Stock Predictions

  • Is ProShares Ultra Nasdaq Biotechnology stock public?
    Yes, ProShares Ultra Nasdaq Biotechnology is a publicly traded company.
  • What is the ProShares Ultra Nasdaq Biotechnology stock quote today?
    The ProShares Ultra Nasdaq Biotechnology stock price is 49.66 USD today.
  • How to buy ProShares Ultra Nasdaq Biotechnology stock online?
    You can buy ProShares Ultra Nasdaq Biotechnology shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-9 54.24 54.84 54.84 54.23
Apr-10 52.80 52.98 53.16 52.45
Apr-11 53.90 53.63 54.01 52.98
Apr-12 52.90 51.31 52.93 50.95
Apr-15 51.61 50.24 51.82 49.90
Apr-16 49.97 49.55 50.20 49.35
Apr-17 49.85 48.95 49.85 48.93
Apr-18 49.00 48.01 49.00 47.94
Apr-19 47.87 48.20 48.68 47.20
Apr-22 48.52 49.11 49.92 48.33
Apr-23 49.66 50.33 51.00 49.66
Apr-24 50.90 50.12 50.90 49.91
Apr-25 49.75 48.94 49.75 47.98
Apr-26 48.86 49.66 49.98 48.84

ProShares Ultra Nasdaq Biotechnology Earnings

Data Unavailable

ProShares Ultra Nasdaq Biotechnology Forecast Revenue Growth

Data Unavailable

* ProShares Ultra Nasdaq Biotechnology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.